C
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NCM – Real vaqt narxi. Valyuta: USD
11.43
+0.39 (3.53%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
11.43
+0.39 (3.53%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Corbus Pharmaceuticals Holdings, Inc., klinik bosqichdagi kompaniya bo'lib, saraton va semirish uchun terapevtik vositalarni ishlab chiqadi va tijoratlashtiradi. Uning ishlab chiqarish quvvati CRB-701 ni o'z ichiga oladi, bu Nectin-4 ning saraton hujayralarida ifodalanishini maqsad qilgan antikor dori birikmasi bo'lib, monometil auristatin E ning sitotoksik yukini chiqaradi; va CRB-913, semirishni davolash uchun periferik cheklangan kannabinoid tipidagi 1 retseptorining teskari agonisti. Kompaniya 2009-yilda tashkil etilgan va Massachusets shtatining Norwood shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Dominic Smethurst M.A., M.D. | Chief Medical Officer |
| Dr. Ian Hodgson B.Sc., Ph.D. | Chief Operating Officer |
| Dr. Yuval Cohen Ph.D. | CEO & Director |
| Mr. G. Scott Goeken J.D., M.S. | General Counsel & Corporate Secretary |
| Mr. Sean F. Moran CPA, M.B.A. | Chief Financial Officer |
| Ms. Christina Bertsch M.A. | Vice President of Human Resources |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-12 | 8-K | crbp-20260512.htm |
| 2026-04-16 | 8-K | crbp-20260415.htm |
| 2026-04-14 | 8-K | crbp-20260414.htm |
| 2026-04-07 | 8-K | crbp-20260401.htm |
| 2026-04-02 | DEF 14A | crbp-20260401.htm |
| 2026-03-11 | S-3 | crbp-20260311.htm |
| 2026-03-09 | 10-K | crbp-20251231.htm |
| 2026-02-25 | 8-K | crbp-20260225.htm |
| 2026-01-12 | 8-K | crbp-20260112.htm |
| 2025-12-18 | 8-K | crbp-20251212.htm |